000 01221 a2200325 4500
005 20250515060458.0
264 0 _c20070905
008 200709s 0 0 eng d
022 _a0007-0963
024 7 _a10.1111/j.1365-2133.2007.07767.x
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aAframian, D J
245 0 0 _aOral adverse effects for escitalopram (Cipralex).
_h[electronic resource]
260 _bThe British journal of dermatology
_cMay 2007
300 _a1046-7 p.
_bdigital
500 _aPublication Type: Case Reports; Letter
650 0 4 _aAdult
650 0 4 _aCitalopram
_xadverse effects
650 0 4 _aDepressive Disorder
_xdrug therapy
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLichenoid Eruptions
_xchemically induced
650 0 4 _aLip Diseases
_xchemically induced
650 0 4 _aMouth Diseases
_xchemically induced
650 0 4 _aMouth Mucosa
_xdrug effects
650 0 4 _aPigmentation Disorders
_xchemically induced
650 0 4 _aSelective Serotonin Reuptake Inhibitors
_xadverse effects
773 0 _tThe British journal of dermatology
_gvol. 156
_gno. 5
_gp. 1046-7
856 4 0 _uhttps://doi.org/10.1111/j.1365-2133.2007.07767.x
_zAvailable from publisher's website
999 _c16884413
_d16884413